Medibank Private Ltd banner

Medibank Private Ltd
XMUN:MPV

Watchlist Manager
Medibank Private Ltd Logo
Medibank Private Ltd
XMUN:MPV
Watchlist
Price: 2.54 EUR -0.78%
Market Cap: €7B

Medibank Private Ltd
Investor Relations

Medibank Private Ltd., a cornerstone of Australia’s healthcare industry, found its origins as a government-run enterprise, established to provide affordable health insurance to Australians. Over the years, it has undergone a significant transformation, becoming a publicly listed company in 2014. Medibank’s journey reflects a broader narrative of innovation and adaptation within the health insurance sector. As one of the leading providers in Australia, it caters to both private individuals and corporate entities, offering a wide range of health insurance products that cover hospital and extras services. This diversification not only strengthens its revenue streams but also positions Medibank as a central player in a competitive market.

At the heart of Medibank's business model lies a dual approach: robust health insurance offerings and a commitment to promoting well-being through preventive healthcare measures. The company generates revenue primarily by collecting premiums from policyholders, which are then used to pay out claims and cover operational costs. Beyond traditional insurance, Medibank has been proactive in investing in digital health platforms and partnerships, enhancing its service delivery with innovative health management programs. Through these initiatives, Medibank aims to reduce long-term healthcare costs by encouraging healthier lifestyles among its members, thereby sustaining its profitability and ensuring customer loyalty. This strategy underscores a keen understanding of the evolving healthcare landscape and a commitment to ensuring sustainable growth.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2026
Call Date
Feb 18, 2026
AI Summary
Q2 2026

Profit Growth: Medibank delivered a 6% increase in group operating profit to $381.7 million, supported by strong health insurance and Medibank Health performance.

Dividend Increase: The interim dividend was raised to $0.083 per share, up 6.4% and representing a 76.8% payout of underlying net profit after tax.

Health Insurance Momentum: Resident policyholders grew 1.9%, with improved retention and growth momentum in both Medibank and ahm brands.

Medibank Health Expansion: Medibank Health segment profit rose 28.5% and revenue grew 27.5%, boosted by organic growth and the Better Medical acquisition.

Expense Guidance: Operating expenses rose 5.4% but management reaffirmed full-year expense guidance of $690–$695 million with $10 million in expected productivity savings.

Claims & Margin Stability: Claims inflation guidance was maintained at 2.6%–2.9% per policy unit, with gross margins broadly stable due to disciplined growth and favorable mix.

Strategic M&A: The Better Medical acquisition strengthens Medibank’s primary care network, and management signaled ongoing appetite and capacity for further acquisitions.

Outlook Unchanged: The company reaffirmed its FY26 outlook, expecting continued disciplined market share growth and ongoing investment in health transformation.

Key Financials
Group Operating Profit
$381.7 million
Underlying EPS
$0.108 per share
Interim Dividend
$0.083 per share
Dividend Payout Ratio
76.8%
Resident Policyholder Growth
1.9%
Medibank Brand Policyholder Growth
0.8%
ahm Policyholder Growth
4.9%
Medibank Health Segment Profit
$48.3 million
Medibank Health Operating Margin
17.7%
Gross Margin (Health Insurance)
16.2%
Health Insurance Operating Profit
$361.5 million
Health Insurance Operating Margin
8.5%
Health Insurance Expense Ratio
7.7%
Resident Claims Growth Per Policy Unit
2.5%
Nonresident Gross Profit
$55.6 million
Nonresident Gross Margin
35.6%
Underlying Net Investment Return
2.74%
Capital Ratio
13.8% of premium revenue
Capital Multiple (PCA)
1.9x
Other Earnings Calls
2026

Management

Mr. David Koczkar B.Com., MAICD, PGDipFinance
CEO, MD & Director
No Bio Available
Mr. Mark Rogers B.Sc., BEng (Hons)
Group Lead - Chief Financial Officer & Group Strategy
No Bio Available
Dr. Andrew Wilson FACHSE, FRANZCP, M.M., MBBS
Group Chief Medical Officer
No Bio Available
Mr. Milosh Milisavljevic
Group Lead - Chief Customer Officer
No Bio Available
Mr. Robert Read B.A., BA(Psych), BComm(Mgt), GAICD
Group Lead ? Amplar Health
No Bio Available
Ms. Felicia Trewin
Group Lead ? Data & Technology
No Bio Available
Colette Campbell
Senior Executive of Investor Relations
No Bio Available
Ms. Mei Ramsay B.A., L.L.B., L.L.M.
Group Lead ? Trust, Legal, Group General Counsel & Company Secretary
No Bio Available
Mr. Tom Exton
Group Lead - Chief Risk & Compliance Officer
No Bio Available
Emily Ritchie
Senior Executive of External Affairs
No Bio Available

Contacts

Address
VICTORIA
Melbourne
720 Bourke Street, Docklands
Contacts
+61386225780.0
www.medibank.com.au
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett